CASI Pharmaceuticals Stock (NASDAQ: CASI) stock price, news, charts, stock research, profile.
You can purchase shares of CASI Pharmaceuticals (NASDAQ:CASI) through any online brokerage.
Other companies in CASI Pharmaceuticals’s space includes: Renovaro (NASDAQ:RENB), CytomX Therapeutics (NASDAQ:CTMX), Cellectar Biosciences (NASDAQ:CLRB), Armata Pharmaceuticals (AMEX:ARMP) and Citius Oncology (NASDAQ:CTOR).
CASI Pharmaceuticals has a consensus price target of $9.33.
The stock price for CASI Pharmaceuticals (NASDAQ: CASI) is $5.87 last updated November 7, 2024 at 4:32 PM EST.
There are no upcoming dividends for CASI Pharmaceuticals.
CASI Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 14, 2024.
There is no upcoming split for CASI Pharmaceuticals.
CASI Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.